Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial. - Perroud A; Madruga JVR; Fernandes L; Luz K; Lukic N; Bourée S; Sanchez-Ruiz M; Pegoraro F; Petit C; Zambrano B; Dayan G (Human vaccines & immunotherapeutics, 2025)